Abstract
For many years, gold therapy has been the mainstay in the management of patients with progressive rheumatoid disease. At the present time two forms of gold therapy are available: one by injection and the other by the oral route. A significant number of patients will achieve clinical benefit from treatment with one of these two compounds. Both compounds have a high prevalence of side-effects and should be regarded as toxic, although the oral preparation appears to have a somewhat better safety profile than has the injectable compound. While resort to these medications should be considered for the treatment of patients who have progressive rheumatoid disease, their use should not be taken lightly. The prescribing physician has an obligation to ensure constant monitoring of patients who are receiving either of these therapies.
Keywords: gold therapy, rheumatoid arthritis
Full text
PDF




Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aaron S., Davis P., Percy J. Neutropenia occurring during the course of chrysotherapy: a review of 25 cases. J Rheumatol. 1985 Oct;12(5):897–899. [PubMed] [Google Scholar]
- Biggs D. F., Boland D. M., Davis P., Wakaruk J. In vitro binding and pharmacokinetics of gold salts in plasma proteins and chelating agents. J Rheumatol Suppl. 1979;5:68–73. [PubMed] [Google Scholar]
- Bombardier C., Ware J., Russell I. J., Larson M., Chalmers A., Read J. L. Auranofin therapy and quality of life in patients with rheumatoid arthritis. Results of a multicenter trial. Am J Med. 1986 Oct;81(4):565–578. doi: 10.1016/0002-9343(86)90539-5. [DOI] [PubMed] [Google Scholar]
- Currey H. L., Harris J., Mason R. M., Woodland J., Beveridge T., Roberts C. J., Vere D. W., Dixon A. S., Davies J., Owen-Smith B. Comparison of azathioprine, cyclophosphamide, and gold in treatment of rheumatoid arthritis. Br Med J. 1974 Sep 28;3(5934):763–766. doi: 10.1136/bmj.3.5934.763. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Davis P., Menard H., Thompson J., Harth M., Beaudet F. One-year comparative study of gold sodium thiomalate and auranofin in the treatment of rheumatoid arthritis. J Rheumatol. 1985 Feb;12(1):60–67. [PubMed] [Google Scholar]
- Dwosh I. L., Stein H. B., Urowitz M. B., Smythe H. A., Hunter T., Ogryzlo M. A. Azathioprine in early rheumatoid arthritis. Comparison with gold and chloroquine. Arthritis Rheum. 1977 Mar;20(2):685–692. doi: 10.1002/art.1780200208. [DOI] [PubMed] [Google Scholar]
- Edelman J., Davis P., Owen E. T. Prevalence of eosinophilia during gold therapy for rheumatoid arthritis. J Rheumatol. 1983 Feb;10(1):121–123. [PubMed] [Google Scholar]
- Favreau M., Tannenbaum H., Lough J. Hepatic toxicity associated with gold therapy. Ann Intern Med. 1977 Dec;87(6):717–719. doi: 10.7326/0003-4819-87-6-717. [DOI] [PubMed] [Google Scholar]
- Fraser T. N. Gold Treatment in Rheumatoid Arthritis. Ann Rheum Dis. 1945 Jun;4(4):71–75. doi: 10.1136/ard.4.4.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gibson T., Huskisson E. C., Wojtulewski J. A., Scott P. J., Balme H. W., Burry H. C., Grahame R., Hart F. D. Evidence that D-penicillamine alters the course of rheumatoid arthritis. Rheumatol Rehabil. 1976 Aug;15(3):211–215. doi: 10.1093/rheumatology/15.3.211. [DOI] [PubMed] [Google Scholar]
- Gould P. W., McCormack P. L., Palmer D. G. Pulmonary damage associated with sodium aurothiomalate therapy. J Rheumatol. 1977 Autumn;4(3):252–260. [PubMed] [Google Scholar]
- Halla J. T., Hardin J. G., Linn J. E. Postinjection nonvasomotor reactions during chrysotherapy. Constitutional and rheumatic symptoms following injections of gold salts. Arthritis Rheum. 1977 Jul-Aug;20(6):1188–1191. doi: 10.1002/art.1780200605. [DOI] [PubMed] [Google Scholar]
- Harth M., Hickey J. P., Coulter W. K., Thompson J. M., Disney T. F. Gold-induced thrombocytopenia. J Rheumatol. 1978 Summer;5(2):165–172. [PubMed] [Google Scholar]
- Heuer M. A., Pietrusko R. G., Morris R. W., Scheffler B. J. An analysis of worldwide safety experience with auranofin. J Rheumatol. 1985 Aug;12(4):695–699. [PubMed] [Google Scholar]
- Kay A. G. Myelotoxicity of gold. Br Med J. 1976 May 22;1(6020):1266–1268. doi: 10.1136/bmj.1.6020.1266. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kean W. F., Anastassiades T. P. Long term chrysotherapy: incidence of toxicity and efficacy during sequential time periods. Arthritis Rheum. 1979 May;22(5):495–501. doi: 10.1002/art.1780220509. [DOI] [PubMed] [Google Scholar]
- Leak A. M., Richter M. R., St Cyr C. H., Ansell B. M. Flurbiprofen is as effective as naproxen in juvenile spondylitis. J Rheumatol. 1986 Jun;13(3):664–665. [PubMed] [Google Scholar]
- Newton P., Swinburn W. R., Swinson D. R. Proteinuria with gold therapy: when should gold be permanently stopped? Br J Rheumatol. 1983 Feb;22(1):11–17. doi: 10.1093/rheumatology/22.1.11. [DOI] [PubMed] [Google Scholar]
- Penneys N. S., Ackerman A. B., Gottlieb N. L. Gold dermatitis. A clinical and histopathological study. Arch Dermatol. 1974 Mar;109(3):372–376. doi: 10.1001/archderm.109.3.372. [DOI] [PubMed] [Google Scholar]
- Percy J. S. Gold in the treatment of Felty's syndrome. J Rheumatol. 1981 Nov-Dec;8(6):878–879. [PubMed] [Google Scholar]
- RESEARCH SUB-COMMITTEE OF THE EMPIRE RHEUMATISM COUNCIL Gold Therapy in Rheumatoid Arthritis: Final Report of a Multicentre Controlled Trial. Ann Rheum Dis. 1961 Dec;20(4):315–334. doi: 10.1136/ard.20.4.315. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Samuels B., Lee J. C., Engleman E. P., Hopper J., Jr Membranous nephropathy in patients with rheumatoid arthritis: relationship to gold therapy. Medicine (Baltimore) 1978 Jul;57(4):319–327. doi: 10.1097/00005792-197807000-00003. [DOI] [PubMed] [Google Scholar]
- Sharp J. T., Lidsky M. D., Duffy J., Thompson H. K., Jr, Person B. D., Masri A. F., Andrianakos A. A. Comparison of two dosage schedules of gold salts in the treatment of rheumatoid arthritis. Relationship of serum gold levels to therapeutic response. Arthritis Rheum. 1977 Jul-Aug;20(6):1179–1187. doi: 10.1002/art.1780200604. [DOI] [PubMed] [Google Scholar]
- Stein H. B., Urowitz M. B. Gold-induced enterocolitis. Case report and literature review. J Rheumatol. 1976 Mar;3(1):21–26. [PubMed] [Google Scholar]
- van Riel P. L., Gribnau F. W., van de Putte L. B., Yap S. H. Loose stools during auranofin treatment: clinical study and some pathogenetic possibilities. J Rheumatol. 1983 Apr;10(2):222–226. [PubMed] [Google Scholar]